@article{article, title  = {{A Phase Ib/II study of IGF-neutralising antibody xentuzumab with enzalutamide in metastatic castration-resistant prostate cancer}},

 publisher = {{Springer Science and Business Media LLC}},

 url = {{https://eprints.whiterose.ac.uk/id/eprint/203278 }},

 year = {{2023}},

 month = {{8}},

 author = {{Macaulay VM and Lord S and Hussain S and Maroto JP and Jones RH and Climent M and Cook N and Lin C-C and Wang S-S and Bianchini D and Bailey M et al}},

 doi = {{10.1038/s41416-023-02380-1}},

 volume = {{129}},

 journal = {{British Journal of Cancer}},

 issue = {{6}},

 pages = {{965-973}},

 note = {{Accessed on 2025/11/05}}}